We are live on ! Find out more
LOXO

Loxo Oncology, Inc
LOXO

Delisted

LOXO was delisted on the 14th of February, 2019.

Back to rankings

72 hedge funds and large institutions have $543M invested in Loxo Oncology, Inc in 2016 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 34 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 16

13% more capital invested

Capital invested by funds: $479M → $543M (+$64.2M)

0% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 8

1% less funds holding

Funds holding: 73 → 72 (-1)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
72
Holders Change
-1
Holders Change %
-1.37%
% of All Funds
1.92%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
8
Increased
34
Reduced
16
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Victory Capital Management
Victory Capital Management
Texas
+$42.1M
2
PC
Paulson & Co
New York
+$12.7M
3
Wellington Management Group
Wellington Management Group
Massachusetts
+$8.2M
4
OM
Opaleye Management
Massachusetts
+$2.88M
5
AG
Artal Group
Luxembourg
+$1.96M

Top Sellers

Rank Fund Capital Flow
1
NMC
NEA Management Company
Maryland
-$13.2M
2
O
OrbiMed
New York
-$11.7M
3
EI
EAM Investors
California
-$3M
4
Axa
Axa
France
-$1.61M
5
Ameriprise
Ameriprise
Minnesota
-$1.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
Geode Capital Management
26
Geode Capital Management
Massachusetts
$2.64M +$91.2K +3,487 +4%
EI
27
EAM Investors
California
$2.23M -$3M -114,669 -57%
JP Morgan Chase
28
JP Morgan Chase
New York
$2.01M +$366K +14,006 +22%
AG
29
Artal Group
Luxembourg
$1.96M +$1.96M +75,000 New
NIP
30
Nicholas Investment Partners
California
$1.77M – – –
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.72M -$821K -31,370 -32%
USAA
32
United Services Automobile Association
Texas
$1.63M +$21.5K +820 +1%
BIM
33
BlackRock Investment Management
Delaware
$1.35M -$2.64K -101 -0.2%
Charles Schwab
34
Charles Schwab
California
$1.07M +$535K +20,449 +99%
Teacher Retirement System of Texas
35
Teacher Retirement System of Texas
Texas
$915K +$875K +33,451 +2,257%
T. Rowe Price Associates
36
T. Rowe Price Associates
Maryland
$868K +$868K +33,163 New
Invesco
37
Invesco
Georgia
$867K +$867K +33,119 New
EA
38
Emerald Acquisition
Washington
$839K -$198K -7,570 -19%
AA
39
ALPS Advisors
Colorado
$723K -$62.7K -2,397 -8%
NFA
40
Nationwide Fund Advisors
Ohio
$573K -$39.2K -1,500 -6%
TA
41
Teachers Advisors
New York
$556K – – –
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$494K +$115K +4,400 +30%
Swiss National Bank
43
Swiss National Bank
Switzerland
$490K -$39.2K -1,500 -7%
Deutsche Bank
44
Deutsche Bank
Germany
$440K +$109K +4,155 +33%
AQR Capital Management
45
AQR Capital Management
Connecticut
$439K +$65.8K +2,515 +18%
MLICM
46
Metropolitan Life Insurance Company (MetLife)
New York
$378K +$101K +3,863 +37%
SO
47
STRS Ohio
Ohio
$342K +$49.4K +1,889 +17%
SCA
48
Secor Capital Advisors
New York
$337K -$45.9K -1,753 -12%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$329K +$22.9K +875 +7%
GCP
50
GSA Capital Partners
United Kingdom
$318K -$60.2K -2,300 -16%
1
2
3 4

LOXO Hedge Fund Activity: Q3 2016 in Review

72 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Loxo Oncology, Inc (LOXO) for Q3 2016, worth a combined $543M — up 13% from $479M a quarter earlier.

Fund positioning in LOXO was balanced in Q3 2016: 8 funds opened new positions, 8 closed out, 34 added to existing stakes and 16 trimmed.

The largest buyer was Victory Capital Management, opening a new position worth an estimated $42.1M. The largest seller was NEA Management Company, cutting an estimated $13.2M.

  • 72 institutional investors held Loxo Oncology, Inc (LOXO) as of Q3 2016, down from 73 in Q2 2016.
  • Funds reported $543M of Loxo Oncology, Inc stock for Q3 2016, up 13% quarter-over-quarter.
  • 8 funds opened new Loxo Oncology, Inc positions in Q3 2016 and 8 closed out, a net change of 0 holders.
  • The largest Loxo Oncology, Inc buyer in Q3 2016 was Victory Capital Management, an estimated $42.1M added.
  • The largest Loxo Oncology, Inc seller in Q3 2016 was NEA Management Company, an estimated $13.2M sold.

Based on aggregated 13F filings for Q3 2016.